# A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens

> **NCT05036343** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 13 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** InPen®

## Key facts

- **NCT ID:** NCT05036343
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-14
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036343, "A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05036343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*